Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study

被引：0
|
作者：
Alex Z Fu
Ying Qiu
Larry Radican
Donald D Yin
Panagiotis Mavros
机构：
[1] Cleveland Clinic,Department of Quantitative Health Sciences
[2] Merck & Co.,Global Outcomes Research
[3] Inc.,undefined
来源：
Cardiovascular Diabetology | / 9卷
关键词：
Metformin; Glycemic Control; Propensity Score; Index Date; Control Cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Glycemic Control of Type 2 Diabetes Mellitus
    Fikree, Majeda
    Hanafi, Baderuldeen
    Hussain, Zahra Ali
    Masuadi, Emad M.
    BAHRAIN MEDICAL BULLETIN, 2006, 28 (03)
  • [32] Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin
    Muggeo, M
    Bolli, G
    Bompiani, G
    Brunetti, P
    Capani, F
    Cavallo-Perin, P
    Comaschi, M
    Cordera, R
    Crepaldi, G
    Cucinotta, D
    Di Mario, U
    Fedele, D
    Ferrannini, E
    Giorgino, R
    Giugliano, D
    Gnudi, A
    Mancini, M
    Menzinger, G
    Pagano, G
    Pontiroli, AE
    Pozza, G
    Santeusanio, F
    Tiengo, BA
    Trovati, M
    Vigneri, R
    DIABETES NUTRITION & METABOLISM, 2000, 13 (04) : 182 - 185
  • [33] Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2
    Lee, Sang Hoon
    Yoon, Sang Hyun
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bock
    Bang, Seungmin
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (04) : 435 - 440
  • [34] Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases
    Tian Li
    Rui Providencia
    Wenhua Jiang
    Manling Liu
    Lu Yu
    Chunhu Gu
    Alex Chia Yu Chang
    Heng Ma
    Drugs, 2022, 82 : 311 - 322
  • [35] Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases
    Li, Tian
    Providencia, Rui
    Jiang, Wenhua
    Liu, Manling
    Yu, Lu
    Gu, Chunhu
    Chang, Alex Chia Yu
    Ma, Heng
    DRUGS, 2022, 82 (03) : 311 - 322
  • [36] Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study
    Li, Jung-Chi
    Cheng, Po-Chung
    Huang, Chien-Nin
    Jian, Li-Fen
    Wu, Ying-Syuan
    Lin, Chih-Li
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
    Huri, Hasniza Zaman
    Ling, Doris Yew Hui
    Ahmed, Wan Azman Wan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4735 - 4749
  • [38] Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
    Vavallo, Antonio
    Simone, Simona
    Lucarelli, Giuseppe
    Rutigliano, Monica
    Galleggiante, Vanessa
    Grandaliano, Giuseppe
    Gesualdo, Loreto
    Campagna, Marcello
    Cariello, Marica
    Ranieri, Elena
    Pertosa, Giovanni
    Lastilla, Gaetano
    Selvaggi, Francesco Paolo
    Ditonno, Pasquale
    Battaglia, Michele
    MEDICINE, 2014, 93 (27)
  • [39] Use of lorcaserin for glycemic control in patients with type 2 diabetes mellitus
    Igel, Leon I.
    Aronne, Louis J.
    OBESITY, 2017, 25 (05) : 816 - 816
  • [40] Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review
    Bin Rakhis, Saud A., Sr.
    AlDuwayhis, Nawaf Mohammed
    Aleid, Naif
    AlBarrak, Abdullah Nasser
    Aloraini, Abdullah Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
12345